R Bredenkamp Selected Research

FUFOX regimen

7/2005

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Bredenkamp Research Topics

Disease

3	Stomach Neoplasms (Stomach Cancer) 01/2007 - 06/2005
3	Neoplasms (Cancer) 01/2007 - 08/2003
3	Adenocarcinoma 01/2007 - 08/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2005 - 08/2003
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2007
1	Breast Neoplasms (Breast Cancer) 06/2005
1	Fever (Fevers) 08/2003

Drug/Important Bio-Agent (IBA)

3	Docetaxel (Taxotere)FDA Link 01/2007 - 08/2003
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2007 - 07/2005
2	Capecitabine (Xeloda)FDA Link 01/2007 - 06/2005
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2007
1	Leucovorin (Folinic Acid)FDA Link 07/2005
1	Fluorouracil (Carac)FDA LinkGeneric 07/2005
1	Cisplatin (Platino)FDA LinkGeneric 08/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2003

Therapy/Procedure

2	Therapeutics 01/2007 - 06/2005
1	Drug Therapy (Chemotherapy) 01/2007
1	FUFOX regimen 07/2005